Showing results (21-30 of 40) with videos related to
Sort By:
Pageof 4
Neuropeptides|June 1, 1996
Functional activity of new C-terminal cyclic-neurotensin fragment analogsH C Akunne, S Darling, K Zoski, et al.Life Sciences|January 1, 1996
In vitro assessment of oral delivery for hexapeptide endothelin antagonistsB H Stewart, E L Reyner, E Tse, et al.Journal of Medicinal Chemistry|October 23, 1998
Design of peptidomimetics that inhibit the association of phosphatidylinositol 3-kinase with platelet-derived growth factor-beta receptor and possess cellular activityS R Eaton, W L Cody, A M Doherty, et al.Journal of Medicinal Chemistry|July 4, 1997
Design of a potent combined pseudopeptide endothelin-A/endothelin-B receptor antagonist, Ac-DBhg16-Leu-Asp-Ile-[NMe]Ile-Trp21 (PD 156252): examination of its pharmacokinetic and spectral propertiesW L Cody, J X He, M D Reily, et al.Journal of Medicinal Chemistry|June 25, 1993
Multiple binding modes for the receptor-bound conformations of cyclic AII agonistsK Plucinska, T Kataoka, M Yodo, et al.Biochemical and Biophysical Research Communications|April 17, 1995
Pharmacological differences between rat and human endothelin B receptorsE E Reynolds, O Hwang, M A Flynn, et al.Bioorganic & Medicinal Chemistry|September 1, 1995
Structure-activity studies of phosphorylated peptide inhibitors of the association of phosphatidylinositol 3-kinase with PDGF-beta receptorK Ramalingam, S R Eaton, W L Cody, et al.Journal of Medicinal Chemistry|January 20, 1995
Design and structure-activity relationships of C-terminal cyclic neurotensin fragment analoguesA M Sefler, J X He, T K Sawyer, et al.Peptides|November 1, 1984
Structural and conformational modifications of alpha-MSH/ACTH4-10 provide melanotropin analogues with highly potent behavioral activitiesM D Hirsch, T L O'Donohue, R Wilson, et al.Biochemical Pharmacology|April 18, 1995
Agonist properties of a stable hexapeptide analog of neurotensin, N alpha MeArg-Lys-Pro-Trp-tLeu-Leu (NT1)H C Akunne, S B Demattos, S Z Whetzel, et al.Pageof 4